sˈɑːɹɡɹɐmˌoʊstɪm ʃˌʊd nˌɑːt biː jˈuːzd ɪn pˈiːpəl wɪð nˈoʊn hˌaɪpɚsˌɛnsɪtˈɪvᵻɾi tə dʒˌiːˈɛmsˌiːˌɛsˈɛf, jˈiːstdᵻɹˈaɪvd pɹˈɑːdʌkts ɔːɹ ˌɛni kəmpˈoʊnənt ʌvðə pɹˈɑːdʌkt ænd fɔːɹ kəŋkˈɑːmɪtənt jˈuːs wɪð kˌiːmoʊθˈɛɹəpi ænd ɹˌeɪdɪoʊθˈɛɹəpi.
Sargramostim should not be used in people with known hypersensitivity to GM-CSF, yeast-derived products or any component of the product and for concomitant use with chemotherapy and radiotherapy.